*The total number of transactions refers to M&A transactions which were announced or announced and closed, and where at least one of the Revenue, EBITDA or EBIT multiples, have been published.
The overall increase in the number of transactions with respect to Q1 2024 was driven by three sectors.
R&CP: The M&A activity decreased to 24 transactions
E&U: The M&A activity increased to 10 transactions
Healthcare: The M&A activity remained unchanged at 14 transactions
IG&S: The M&A activity increased to 45 transactions
MT&T: The M&A activity increased to 43 transactions
CC&M: The M&A activity remained unchanged at 12 transactions